Business headlines from the Apex backend, organized by sectors and major public companies for faster market scanning.
Recent brokerage notes are split on Salesforce as the company leans on acquisitions to accelerate “agentic” AI inside its customer-service and sales software ecosystem. A Guggenheim upgrade to Buy contrasts with a Phillip Securities downgrade to Neutral, reflecting differing views on valuation and AI monetization timing.
THE APEX TIMES
THE APEX TIMES
A fresh market analysis argues that after a strong multi-year run, CVS Health shares now look more priced for solid performance than positioned as a clear bargain.
THE APEX TIMES
The TV commentator linked Palantir’s upbeat first-quarter revenue and guidance raise to a valuation he called unusually low, while also citing enterprise AI contract dynamics and highlighting other AI-exposed software names.
THE APEX TIMES
A Jefferies senior analyst argues Meta has the financial capacity to build out enterprise AI infrastructure, but is arriving years after dominant cloud rivals have already locked up much of the demand.
THE APEX TIMES
The e-commerce and cloud giant says its Louisiana operations have grown to 8,500-plus employees and a network of education partners tied to its Career Choice program.
THE APEX TIMES
Reports say Adobe (ADBE) has reached a deal involving Topaz Labs that would add AI enhancement capabilities to its Firefly generative AI platform, underscoring the company’s push to make the software ecosystem central to how digital content is made.
THE APEX TIMES
A recent market-focused review argues Mastercard (MA) is set up to challenge Wall Street expectations again, pointing to the company’s past earnings surprises and what the note describes as the key conditions behind them.
THE APEX TIMES
A ratings downgrade and a sharply reduced price target underscore how analysts are recalibrating expectations for Adobe’s AI-led push amid evidence of slowing growth.
THE APEX TIMES
Meta Platforms climbed 8.8% in the last session on trading volume above normal. A separate look at analysts’ earnings estimate revisions suggested the move may face limits in the near term.
